 Shares of Kezar Life Sciences are up an astounding 74 today after the biotechnology company reported positive results from its clinical trial regarding a treatment for the autoimmune disease Lupus. The post Kezar Life Sciences KZR Stock Soars on Lupus Trial Results appeared first on InvestorPlace. 